
Procter & Gamble Health Limited – NSE:PGHL.NS
Procter & Gamble Health Limited stock price today
Procter & Gamble Health Limited stock price monthly change
Procter & Gamble Health Limited stock price quarterly change
Procter & Gamble Health Limited stock price yearly change
Procter & Gamble Health Limited key metrics
Market Cap | 90.08B |
Enterprise value | 85.41B |
P/E | 40.30 |
EV/Sales | 7.36 |
EV/EBITDA | 26.33 |
Price/Sales | 7.56 |
Price/Book | 16.30 |
PEG ratio | 4.66 |
EPS | 128.93 |
Revenue | 11.68B |
EBITDA | 3.17B |
Income | 2.14B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 18.77% |
Oper. margin | 26.5% |
Gross margin | 52.03% |
EBIT margin | 26.5% |
EBITDA margin | 27.13% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeProcter & Gamble Health Limited stock price history
Procter & Gamble Health Limited stock forecast
Procter & Gamble Health Limited financial statements
Jun 2023 | 3.01B | 298.2M | 9.9% |
---|---|---|---|
Sep 2023 | 3.04B | 655.7M | 21.5% |
Dec 2023 | 3.09B | 720.7M | 23.25% |
Mar 2024 | 2.52B | 465.6M | 18.44% |
Payout ratio | 0% |
---|
2016 | 0.75% |
---|---|
2017 | 0.83% |
2018 | 0.49% |
2020 | 13.08% |
2022 | 4.08% |
Dec 2022 | 10795200000 | 3.45B | 31.96% |
---|---|---|---|
Sep 2023 | 0 | 0 | |
Dec 2023 | 10770500000 | 2.71B | 25.18% |
Mar 2024 | 0 | 0 |
Jun 2023 | 0 | 0 | 0 |
---|---|---|---|
Sep 2023 | 0 | 0 | 0 |
Dec 2023 | 0 | 0 | 0 |
Mar 2024 | 0 | 0 | 0 |
Procter & Gamble Health Limited alternative data
Aug 2023 | 1,368 |
---|---|
Sep 2023 | 1,368 |
Oct 2023 | 1,368 |
Nov 2023 | 1,368 |
Dec 2023 | 1,407 |
Jan 2024 | 1,407 |
Feb 2024 | 1,407 |
Mar 2024 | 1,407 |
Apr 2024 | 1,407 |
May 2024 | 1,407 |
Jun 2024 | 1,407 |
Jul 2024 | 1,407 |
Procter & Gamble Health Limited other data
Insider | Compensation |
---|---|
Mr. Milind Vasant Thatte M.B.A. (1969) MD & Executive Director | $32,340,000 |
Mr. Amit Gupta (1976) Executive Director of Fin., Chief Financial Officer & Whole Time Director | $16,680,000 |
-
What's the price of Procter & Gamble Health Limited stock today?
One share of Procter & Gamble Health Limited stock can currently be purchased for approximately $5,251.5.
-
When is Procter & Gamble Health Limited's next earnings date?
Unfortunately, Procter & Gamble Health Limited's (PGHL.NS) next earnings date is currently unknown.
-
Does Procter & Gamble Health Limited pay dividends?
Yes, Procter & Gamble Health Limited pays dividends and its trailing 12-month yield is 2.08% with 0% payout ratio. The last Procter & Gamble Health Limited stock dividend of $0 was paid on 5 Sep 2025.
-
How much money does Procter & Gamble Health Limited make?
Procter & Gamble Health Limited has a market capitalization of 90.08B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5.42% to 11.51B US dollars.
-
What is Procter & Gamble Health Limited's stock symbol?
Procter & Gamble Health Limited is traded on the NSE under the ticker symbol "PGHL.NS".
-
What is Procter & Gamble Health Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Procter & Gamble Health Limited?
Shares of Procter & Gamble Health Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Procter & Gamble Health Limited's key executives?
Procter & Gamble Health Limited's management team includes the following people:
- Mr. Milind Vasant Thatte M.B.A. MD & Executive Director(age: 56, pay: $32,340,000)
- Mr. Amit Gupta Executive Director of Fin., Chief Financial Officer & Whole Time Director(age: 49, pay: $16,680,000)
-
How many employees does Procter & Gamble Health Limited have?
As Jul 2024, Procter & Gamble Health Limited employs 1,407 workers.
-
When Procter & Gamble Health Limited went public?
Procter & Gamble Health Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.
-
What is Procter & Gamble Health Limited's official website?
The official website for Procter & Gamble Health Limited is pghealthindia.com.
-
How can i contact Procter & Gamble Health Limited?
Procter & Gamble Health Limited can be reached via phone at +91 22 6866 9000.
Procter & Gamble Health Limited company profile:

Procter & Gamble Health Limited
pghealthindia.comNSE
1,407
Drug Manufacturers - Specialty & Generic
Healthcare
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.
Mumbai, 400079
:
ISIN: INE199A01012
CUSIP: Y6008J118